Statement on Terminating the Letter of Intent With AI Financial Corporation July 14, 2026 Statement from Matthew Nicoletti, Chief Strategy Officer, Perpetuals.com (Nasdaq: PDC), on the proposed transaction with AI Financial Corporation. “Perpetuals has decided not to further pursue the acquisition of AI Financial Corporation’s subsidiary Alt5 Sigma Canada, Inc. and the earlier letter of intent has been terminated.” About Perpetuals.com Ltd Perpetuals.com Ltd (Nasdaq: PDC) is a fintech [...]
The Octus MCP Connector Puts the Most Expansive, Accurate and Verified Credit Intelligence and Data Directly Inside Claude, ChatGPT and Other LLMs July 14, 2026 Octus subscribers can now route credit intelligence, data and deal documents directly into the AI tools they use every day, with source attribution on every output
RS2 Financial Services GmbH Selected to Participate in ECB Digital Euro Pilot July 14, 2026 German-regulated e-money institution will contribute acquiring expertise to practical testing of a possible future digital euro
Rehlko Announces €12 Million Expansion of Power Control & Distribution Manufacturing Facility in Cholet, France July 14, 2026 Strategic investment scales Cholet production facility by over 50%, reducing lead time by 30% to meet growing digital infrastructure demand
New Oxford Economics Study Shows the Social and Economic Impact of Bars July 14, 2026 Commissioned in partnership with AB InBev, the report examines how people around the world turn to bars to connect and build community
Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION July 14, 2026 Non-arteritic anterior ischemic optic neuropathy (NAION) is a loss of blood flow to the optic nerve which causes spontaneous and rapid vision loss, for which there are currently no FDA-approved treatments. Given the substantial unmet need for effective treatments in NAION, in October 2025, Dompé was awarded a Commissioner’s National Priority Review Voucher (CNPV) by the US FDA to accelerate a potential Biologics License Application for intranasal nerve growth factor (NGF) in NAION.
ACE Welcomes Telekom Srbija Group as Newest Member, Expanding Anti-Piracy Fight in Southeast Europe July 14, 2026 Top Telecommunications and Media Group Joins Global Coalition Protecting Creative Content and Strengthening Lawful Digital Markets
STARTEEPO Increases Xerox Position to 8.8 Million Shares, Becomes Second-Largest Common Shareholder July 14, 2026 STARTEEPO Invest (“STARTEEPO”), a Prague-based alternative investment fund focused on high-conviction public equity investments, today announced that it has increased its beneficial ownership position in Xerox Holdings Corporation (“Xerox” or the “Company”) to 8.8 million common shares, together with options on an additional 140,000 shares, as disclosed in an amended Schedule 13D filing with the [...]
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization July 14, 2026 The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
U.K. Firms Move to AI-Native, Sovereign Cloud Infrastructure July 14, 2026 Organizations seek to modernize IT environments to balance resilience and sustainability as AI adoption accelerates, ISG Provider Lens® report says
